These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24800526)

  • 21. Beta-adrenoceptor antagonists in elderly patients with chronic heart failure: therapeutic potential of third-generation agents.
    Coats AJ
    Drugs Aging; 2006; 23(2):93-9. PubMed ID: 16536633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical and metabolic effects of cardioselective beta-adrenoblockers nebivolol and metoprolol in patients with hypertension and ischemic heart disease associated with type 2 diabetes].
    Makolkin VI; Akhmedova OO; Buval'tsev VI; Gavrilov IuV; Petriĭ VV
    Kardiologiia; 2003; 43(2):40-3. PubMed ID: 12891271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic profile of nebivolol, a beta-adrenoceptor antagonist with unique characteristics.
    Agabiti Rosei E; Rizzoni D
    Drugs; 2007; 67(8):1097-107. PubMed ID: 17521213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerability of nebivolol compared with other antihypertensive drugs: a meta-analysis.
    Van Bortel LM; Fici F; Mascagni F
    Am J Cardiovasc Drugs; 2008; 8(1):35-44. PubMed ID: 18303936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The foundation role of beta blockers across the cardiovascular disease spectrum: a year 2009 update.
    Black HR; Greenberg BH; Weber MA
    Am J Med; 2010 Nov; 123(11):S2. PubMed ID: 21035578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute and 14-day hepatic venous pressure gradient response to carvedilol and nebivolol in patients with liver cirrhosis.
    Silkauskaitė V; Kupčinskas J; Pranculis A; Jonaitis L; Petrenkienė V; Kupčinskas L
    Medicina (Kaunas); 2013; 49(11):467-73. PubMed ID: 24823927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New beta-blocker gets FDA approval.
    Traynor K
    Am J Health Syst Pharm; 2008 Feb; 65(3):190. PubMed ID: 18215997
    [No Abstract]   [Full Text] [Related]  

  • 28. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Beta-adrenoblockers for the correction of arterial hypertension in postmenopausal women].
    Latfullin IA; Ishmurzin GP; Gaĭfullina RF; Akhmerova RI; Kim ZF; Podol'skaia AA
    Klin Med (Mosk); 2010; 88(2):68-71. PubMed ID: 21105477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of low-dose carvedilol, nebivolol, and metoprolol on central arterial pressure and its determinants: a randomized clinical trial.
    Studinger P; Tabák ÁG; Chen CH; Salvi P; Othmane TE; Torzsa P; Kapocsi J; Fekete BC; Tislér A
    J Clin Hypertens (Greenwich); 2013 Dec; 15(12):910-7. PubMed ID: 24119182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What is the role, if any, for beta-blockers as initial therapy for uncomplicated hypertension?
    Pedersen ME; Cockcroft JR
    Curr Opin Cardiol; 2009 Jul; 24(4):325-32. PubMed ID: 19417638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nebivolol: a review of its use in the management of hypertension and chronic heart failure.
    Moen MD; Wagstaff AJ
    Drugs; 2006; 66(10):1389-409; discussion 1410. PubMed ID: 16903772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nebivolol: a new beta blocker on the horizon.
    Katira R; Chauhan A
    Indian Heart J; 2000; 52(1):86-8. PubMed ID: 10820942
    [No Abstract]   [Full Text] [Related]  

  • 34. Nitric oxide mechanisms of nebivolol.
    Maffei A; Lembo G
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):317-27. PubMed ID: 19443516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic effects of nebivolol].
    Agabiti-Rosei E; Salvetti M; Monteduro C
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):365-8. PubMed ID: 12497936
    [No Abstract]   [Full Text] [Related]  

  • 36. [Economic analysis of the treatment of heart failure with beta-blockers].
    Díez-Manglano J
    Med Clin (Barc); 2013 Sep; 141(6):265-70. PubMed ID: 23597957
    [No Abstract]   [Full Text] [Related]  

  • 37. Pulmonary effects of nebivolol.
    Dal Negro R
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):329-34. PubMed ID: 19638367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidative stress and TGFbeta in kidney-transplanted patients with cyclosporin-induced hypertension. Effect of carvedilol and nifedipine.
    Calò L; Giacon B; Davis PA; Pagnin E; Piccin A; Riegler P; Huber W; Antonello A; Semplicini A
    Clin Nephrol; 2002 Aug; 58(2):103-10. PubMed ID: 12227681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Both carvedilol and nebivolol may improve platelet function and prothrombotic state in patients with nonischemic heart failure.
    Karabacak M; Dogan A; Aksoy F; Ozaydin M; Erdogan D; Karabacak P
    Angiology; 2014 Jul; 65(6):533-7. PubMed ID: 23671213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of arterial and renal nitric oxide bioavailability in hypertensive rats with diabetes: effect of beta-blockers.
    Mason RP; Kubant R; Jacob RF; Malinski P; Huang X; Louka FR; Borowiec J; Mizuno Y; Malinski T
    Am J Hypertens; 2009 Nov; 22(11):1160-6. PubMed ID: 19730416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.